ArticlePloS one2013
The rationale for consuming cognitive enhancement drugs in university students and teachers.
Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 69 citations in OpenAlex.
- A norm about harvest division is maintained by a desire to follow tradition, not by social policing.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Factors influencing the use of natural health products, in particular for concentration and cognition in Germany.BMC complementary medicine and therapies · 2024Article
- Do Medical Universities Students Use Cognitive Enhancers while Learning?-Conclusions from the Study in Poland.Life (Basel, Switzerland) · 2023Article
- Parents' Perceptions on the Debated Parenting Practice of Cognitive Enhancement in Healthy Children and Adolescents.Journal of cognitive enhancement : towards the integration of theory and practice · 2022Article
- Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior.Science and engineering ethics · 2021Article
- Understanding the relationship between safety beliefs and knowledge for cognitive enhancers in UK university students.PloS one · 2021Article
- The Dark Triad of personality and attitudes toward cognitive enhancement.BMC psychology · 2020Article
- Professionals' attitudes towards the use of cognitive enhancers in academic settings.PloS one · 2020Article
- How perceived substance characteristics affect ethical judgement towards cognitive enhancement.PloS one · 2019Article
- Prevalence and correlates of stimulant and depressant pharmacological cognitive enhancement among Norwegian students.Nordisk alkohol- & narkotikatidskrift : NAT · 2018Article
- Bottom Up Ethics - Neuroenhancement in Education and Employment.Neuroethics · 2018Article
- Pharmacological Neuroenhancement: teachers' knowledge and attitudes-Results from a survey study among teachers in Germany.Substance abuse treatment, prevention, and policy · 2016Article
- Using Caffeine Pills for Performance Enhancement. An Experimental Study on University Students' Willingness and Their Intention to Try Neuroenhancements.Frontiers in psychology · 2016Article
- Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.Frontiers in psychology · 2016Article
- Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement.Frontiers in psychology · 2015Article
- Article
- Article
- Performance enhancement in the workplace: why and when healthy individuals should disclose their reliance on pharmaceutical cognitive enhancers.Frontiers in systems neuroscience · 2015Article
- Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.Substance abuse treatment, prevention, and policy · 2014Article
- Attitudes toward pharmacological cognitive enhancement-a review.Frontiers in systems neuroscience · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive enhancement (CE) is the pharmaceutical augmentation of mental abilities (e.g., learning or memory) without medical necessity. This topic has recently attracted widespread attention in scientific and social circles. However, knowledge regarding the mechanisms that underlie the decision to use CE medication is limited. To analyze these decisions, we used data from two online surveys of randomly sampled university teachers (N = 1,406) and students (N = 3,486). Each respondent evaluated one randomly selected vignette with regard to a hypothetical CE drug. We experimentally varied the characteristics of the drugs among vignettes and distributed them among respondents. In addition, the respondent's internalization of social norms with respect to CE drug use was measured. Our results revealed that students were more willing to enhance cognitive performance via drugs than university teachers, although the overall willingness was low. The probability of side effects and their strength reduced the willingness to use CE drugs among students and university teachers, whereas higher likelihoods and magnitudes of CE increased this propensity. In addition, the internalized norm against CE drug use influenced decision making: Higher internalization decreased the willingness to use such medications. Students' internalized norms more strongly affected CE abstinence compared with those of university teachers. Furthermore, internalized norms negatively interacted with the instrumental incentives for taking CE medication. This internalization limited the influence of and deliberation on instrumental incentives. This study is the first to provide empirical evidence regarding the importance of social norms and their influence on rational decision making with regard to CE. We identified previously undiscovered decision-making patterns concerning CE. Thus, this study provides insight into the motivators and inhibitors of CE drug use. These findings have implications for contending with CE behavior by highlighting the magnitude of potential side effects and by informing the debate regarding the ethics of CE use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.